High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemia
Résumé
Abstract Histologic transformation of Waldenström macroglobulinemia (HT-WM) carries a poor prognosis with standard treatments. Here, we report the first series of HT-WM treated with chimeric antigen receptor T cells showing a high efficacy and no unexpected toxicity.
Domaines
Cancer
Fichier principal
Durot et al. - 2024 - High efficacy of CD19 CAR T-cells in patients with.pdf (718.45 Ko)
Télécharger le fichier
Origine | Fichiers produits par l'(les) auteur(s) |
---|